Bristol-Myers Squibb Company (NYSE: BMY) ranks among the top stocks for an early retirement portfolio. On June 12, Cantor ...

Bristol-Myers Squibb Company (NYSE:BMY) is the third biopharmaceutical company on the list of the 10 undervalued blue chip ...

Discover 23 high-dividend stocks that outshine treasuries! Learn why growing dividends signal financial strength and explore ...

Bristol Myers Squibb (BMY) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

Bristol-Myers Squibb has secured a pivotal FDA orphan drug designation for its sickle cell disease treatment, signaling a ...

Pharma/biotech giants Pfizer PFE and Bristol Myers BMY boast of a dominant position in the lucrative oncology space. Oncology ...

Rockland Trust Co. has cut its Bristol-Myers Squibb stake by 10.3%, shedding 20,035 shares, now holding a still-mighty $10.7 ...

(Reuters) -German biotech firm BioNTech has agreed to acquire domestic peer CureVac for about $1.25 billion worth of BioNTech ...

Should BMY stock rise through the short strike price of $48 at expiration, the maximum reward is $53, a payout of nearly 113%. To be clear, both legs of the 47/48 call spread are out the money, ...

Zacks.com users have recently been watching Bristol Myers (BMY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Investors in Bristol Myers Squibb Co. (Symbol: BMY) saw new options begin trading today, for the May 30th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ...